Harvard Bioscience Inc
NASDAQ:HBIO
Harvard Bioscience Inc
Operating Income
Harvard Bioscience Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Harvard Bioscience Inc
NASDAQ:HBIO
|
Operating Income
$2.3m
|
CAGR 3-Years
125%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-12%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Operating Income
$7.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
Danaher Corp
NYSE:DHR
|
Operating Income
$9.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Operating Income
$1.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Agilent Technologies Inc
NYSE:A
|
Operating Income
$1.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Operating Income
$2.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
See Also
What is Harvard Bioscience Inc's Operating Income?
Operating Income
2.3m
USD
Based on the financial report for Dec 31, 2023, Harvard Bioscience Inc's Operating Income amounts to 2.3m USD.
What is Harvard Bioscience Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-12%
The average annual Operating Income growth rates for Harvard Bioscience Inc have been 125% over the past three years , -14% over the past five years , and -12% over the past ten years .